← All companies

BBTX

Bambusa Therapeutics, Inc.

BBTX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$15.73

-0.12 -0.76%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$13.60 – $17.42

Recent SEC filings

30 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Regulation FD disclosure Nov 3, 2026

Other filings

SCHEDULE 13D Nov 6, 2026

SCHEDULE 13G Nov 5, 2026

424B4 Oct 30, 2026

S-8 Oct 30, 2026

EFFECT Oct 29, 2026

S-1MEF Oct 29, 2026

CERT Oct 29, 2026

8-A12B Oct 27, 2026

S-1/A Oct 26, 2026

S-1 Oct 9, 2026

DRS/A Sep 15, 2026

DRS Aug 3, 2026

D Item 06b Feb 26, 2025

D Item 06b Jan 8, 2025

D Item 06b Jan 8, 2025